We are live on
!
Find out more
MCM
Moore Capital Management Portfolio holdings
AUM
$4.92B
1-Year Est. Return
35.41%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.41%
3 Year Est. Return
+169.06%
5 Year Est. Return
+282.2%
10 Year Est. Return
+2,041.62%
AUM
$4.15B
AUM Growth
-$740M
(-15%)
Cap. Flow
-$934M
Cap. Flow
% of AUM
-22.49%
Top 10 Holdings %
Top 10 Hldgs %
25.81%
Holding
662
New
212
Increased
104
Reduced
104
Closed
195
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$89.8M |
| 2 |
Procter & Gamble
PG
|
+$52.4M |
| 3 |
Baidu
BIDU
|
+$46.2M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$40.5M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$35.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$268M |
| 2 |
Gilead Sciences
GILD
|
+$159M |
| 3 |
Herc Holdings
HRI
|
+$148M |
| 4 |
Citigroup
C
|
+$112M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.15% |
| 2 | Communication Services | 8.5% |
| 3 | Consumer Discretionary | 6.43% |
| 4 | Technology | 5.27% |
| 5 | Consumer Staples | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
226
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.4M | 0.08% |
+100,000
| New | +$3.13M |
|
|
CHS
227
CALL
DELISTED
Chicos FAS, Inc.
CHS
| $3.39M | 0.08% |
200,000
-200,000
| -50% | -$3.2M |
|
228
Lam Research
LRCX
$382B
| $3.38M | 0.08% |
500,000
+418,740
| +515% | +$2.5M |
|
|
NE
229
CALL
DELISTED
Noble Corporation
NE
| $3.36M | 0.08% |
114,400
| – | – |
|
230
Honeywell
HON
$77.1B
| $3.28M | 0.08% |
39,317
+9,311
| +31% | +$778K |
|
231
CALL
JetBlue
JBLU
$1.96B
| $3.25M | 0.08% |
300,000
-700,000
| -70% | -$6.47M |
|
232
LiveRamp
RAMP
$2.29B
| $3.25M | 0.08% |
+150,000
| New | +$3.87M |
|
233
Forestar Group
FOR
$1.44B
| $3.25M | 0.08% |
170,426
| – | – |
|
234
Ubiquiti
UI
$31.8B
| $3.23M | 0.08% |
71,526
+38,270
| +115% | +$1.5M |
|
|
PDCE
235
DELISTED
PDC Energy, Inc.
PDCE
| $3.16M | 0.08% |
50,000
| – | – |
|
236
PepsiCo
PEP
$186B
| $3.13M | 0.08% |
35,000
-15,000
| -30% | -$1.3M |
|
237
Danaher
DHR
$135B
| $3.1M | 0.07% |
58,628
+10,583
| +22% | +$544K |
|
238
Ambev
ABEV
$47.3B
| $3.1M | 0.07% |
+440,000
| New | +$3.24M |
|
239
Union Pacific
UNP
$183B
| $3.1M | 0.07% |
31,048
-22,572
| -42% | -$2.19M |
|
240
Estee Lauder
EL
$29B
| $3.04M | 0.07% |
+41,000
| New | +$3.01M |
|
|
TIME
241
DELISTED
Time Inc.
TIME
| $3.03M | 0.07% |
+125,000
| New | +$2.93M |
|
|
AUXL
242
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $3.01M | 0.07% |
+150,000
| New | +$3.44M |
|
243
AstraZeneca
AZN
$263B
| $2.97M | 0.07% |
+40,000
| New | +$2.89M |
|
|
DRC
244
DELISTED
DRESSER-RAND GROUP INC
DRC
| $2.87M | 0.07% |
+45,000
| New | +$2.75M |
|
245
Boise Cascade
BCC
$2.74B
| $2.86M | 0.07% |
+100,000
| New | +$2.67M |
|
246
Monster Beverage
MNST
$91.4B
| $2.84M | 0.07% |
240,000
+204,432
| +575% | +$2.33M |
|
|
GDEF
247
DELISTED
GLOBAL DEFENSE & NATIONAL SECURITY SYSTEMS INC COM
GDEF
| $2.81M | 0.07% |
275,000
| – | – |
|
248
PVH
PVH
$3.71B
| $2.8M | 0.07% |
+23,980
| New | +$2.98M |
|
|
RHT
249
DELISTED
Red Hat Inc
RHT
| $2.76M | 0.07% |
+50,000
| New | +$2.54M |
|
|
WFT
250
DELISTED
Weatherford International plc
WFT
| $2.76M | 0.07% |
+120,000
| New | +$2.47M |
|
Similar funds
MSRPS
SIA
FC
SMFG
KCM
PBA
DGI
FFB
Moore Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Moore Capital Management held 662 positions worth $4.15B, down 15% from $4.89B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Moore Capital Management withdrew a net $934M in Q2 2014, closing 195 positions and reducing 104 holdings. Its most notable exit was Gilead Sciences, an estimated $159M position sold in full.
By sector, the portfolio is most concentrated in Financials at 9.1% of assets, down from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Moore Capital Management opened a new position in Procter & Gamble worth $51.1M.
- Moore Capital Management's largest Q2 2014 buy was Procter & Gamble: 650,000 shares worth $51.1M.
- Moore Capital Management added most to Apple in Q2 2014, an estimated $89.8M increase.
- Moore Capital Management's biggest Q2 2014 reduction was JPMorgan Chase, cutting an estimated $268M.
- Moore Capital Management fully exited Gilead Sciences in Q2 2014, selling an estimated $159M.
- Moore Capital Management's ten largest holdings make up 26% of its $4.15B portfolio in Q2 2014.
- Moore Capital Management opened 212 new positions and closed 195 in Q2 2014.
- Moore Capital Management's portfolio value fell 15% quarter-over-quarter to $4.15B.
Based on Moore Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.